Richard G. Bostedor - Concepedia

Author

Richard G. Bostedor

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Richard Bostedor, Richard G Bostedor, Richard G. Bostedor

Publications

897

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Richard G. Bostedor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	8	8	720
2	Medicine	7	7	459
3	Natural Sciences	4	4	536
4	Biomolecular Engineering	2	2	433
5	Health Sciences	1	1	46

Richard G. Bostedor

Publications

892

Citations

H-Index

Page 1

	Year	Citations
Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase James D. Bergstrom, Richard G. Bostedor, P. Masarachia, Archives of Biochemistry and Biophysics BiochemistryNatural SciencesBiocatalysisDrug DiscoveryEnzyme Catalysis	2000	398
Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo John I. Germershausen, V. M. Hunt, Richard G. Bostedor, Biochemical and Biophysical Research Communications InflammationCholesterol-lowering Agents LovastatinCardiovascular DiseaseMedicinePhysiology	1989	172
Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol Richard G. Bostedor, John D. Karkas, Byron H. Arison, Journal of Biological Chemistry Animal PhysiologyAnimals TreatedPharmacological StudyBiochemistrySqualene Synthase	1997	67
Cloning, analysis, and bacterial expression of human farnesyl pyrophosphate synthetase and its regulation in Hep G2 cells B T Sheares, Sylvia S. White, David T. Molowa, Biochemistry Molecular RegulationMolecular BiologyMolecular GeneticsRat Liver CdnasProtein Synthesis	1989	59
Massive Production of Farnesol-Derived Dicarboxylic Acids in Mice Treated with the Squalene Synthase Inhibitor Zaragozic Acid A Sanskruti Vaidya, Richard G. Bostedor, Marc M. Kurtz, Archives of Biochemistry and Biophysics BiochemistryMedicineMice TreatedMassive ProductionDrug Development	1998	53
Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin James D. Bergstrom, Richard G. Bostedor, Deborah J. Rew, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Hepatic ResponsesHepatologyBiochemistryMedicineLiver Physiology	1998	46
A comparison of the antiviral agents 2′-nor-2′-deoxyguanosine and acyclovir: Uptake and phosphorylation in tissue culture and kinetics of in vitro inhibition of viral and cellular DNA polymerases by their respective triphosphates John I. Germershausen, Richard G. Bostedor, Anjalie Field, Biochemical and Biophysical Research Communications Viral ReplicationRespective TriphosphatesViral Polymerase StructureBiochemistryCellular Dna Polymerases	1983	44
Stereochemical considerations in the enzymatic phosphorylation and antiviral activity of acyclonucleosides. I. Phosphorylation of 2′-nor-2′-deoxyguanosine John D. Karkas, John I. Germershausen, Richard L. Tolman, Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology Bioorganic ChemistryBiochemistryAntiviral ActivityStereochemical ConsiderationsI. Phosphorylation	1987	35
Inverse relationship between galactokinase activity and 2-deoxygalactose resistance in Chinese hamster ovary cells Carolyn D. Whitfield, Bruce L. Buchsbaum, Richard G. Bostedor, Somatic Cell and Molecular Genetics Biochemistry2-Deoxygalactose ResistanceLipid PeroxidationPhysiologyGlycobiology	1978	18

Page 1